Markets:

Overview

News

Currencies

International

Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.345 -0.055 (-1.25%)

Streaming Delayed Price Updated: 12:07 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >

Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗

Today 9:13 EST

Cytek (CTKB) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗

February 26, 2026

Via Chartmill

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗

November 14, 2025

Via Benzinga

Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗

November 05, 2025

Cytek (CTKB) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Intellectual Property World Trade

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November ↗

December 30, 2024

Via Benzinga

Crude Oil Gains 1%; Chicago PMI Falls In December ↗

December 30, 2024

Via Benzinga

Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday ↗

December 30, 2024

Via Benzinga

Preview: Cytek Biosciences's Earnings ↗

November 04, 2024

Via Benzinga

The Latest Analyst Ratings for Cytek Biosciences ↗

December 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 19, 2024

Via Benzinga

Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views ↗

November 06, 2024

Via Benzinga

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results ↗

November 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 06, 2024

Via Benzinga

Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday ↗

November 06, 2024

Via Benzinga

CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023 ↗

March 27, 2024

CTKB stock results show that Cytek Biosciences beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday ↗

March 04, 2024

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Via Benzinga

Topics Stocks

Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says ↗

December 14, 2023

Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and services.

Via Benzinga

Topics Supply Chain

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 07, 2023

Via Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Cytek Biosciences: Here's What You Need To Know ↗

October 24, 2023

Via Benzinga

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.